Not Yet RecruitingNot Applicable

LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice

Italy20,000 participantsStarted 2026-01

Plain-language summary

This multicenter retrospective observational registry study will collect existing clinical data from Italian centers to describe epidemiology, treatment patterns, clinical evolution, safety, and comorbidities in patients aged 12 years and older with psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Documented diagnosis of psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa.
✓. Age 12 years or older at the first recorded visit.
✓. Eligible for or treated with systemic therapies.
✓. At least one documented visit during January 2016 to December 2025.
✓. No opt-out exercised.

Exclusion criteria

✕. Opt-out exercised.
✕. Medical records with insufficient data.

What they're measuring

Patient Distribution by Disease Type

Timeframe: January 2016 to December 2025

Age at Treatment Initiation

Timeframe: January 2016 to December 2025

Sex Distribution

Timeframe: January 2016 to December 2025

Trial details

NCT IDNCT07336641

SponsorFondazione ISIDE

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-05

Contact for this trial

Dario Gattuso

3792225577 ricerca@fondazioneiside.org

View on ClinicalTrials.gov More Psoriasis trials